Literature DB >> 22009494

Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth.

Giuseppe Nolfe1, Maria Rita Spreghini, Rita Wietrzycowska Sforza, Giuseppe Morino, Melania Manco.   

Abstract

BACKGROUND: To describe the morphology of glucose curve during the oral glucose tolerance test (OGTT) and any association with glucose tolerance, insulin action and secretion in obese youth. STUDY
DESIGN: Cross-sectional.
METHODS: OGTT data of 553 patients were analysed. Subjects were divided in groups based on the morphology (i.e. monophasic, biphasic, triphasic and upward monotonous) of glucose curve. Insulin action was estimated by the homeostasis model assessment of insulin resistance, the insulin sensitivity, the muscle insulin sensitivity and the hepatic insulin resistance indexes (HIRI), and the oral glucose insulin sensitivity (OGIS). Insulin secretion was estimated by the insulinogenic index (IGI). Disposition index, including the insulin secretion-sensitivity index-2, and areas under glucose (AUC(G)) and insulin (AUC(I)) curves were computed.
RESULTS: In patients with normal glucose tolerance (n=522), prevalent morphology of the glucose curve was monophasic (n=285, 54%). Monophasic morphology was associated with the highest concentration of 1 h plasma glucose (P<0.0001) and AUC(G) (P<0.0001); biphasic morphology with better insulin sensitivity as estimated by OGIS (P<0.03) and lower AUC(I) (P<0.0001); triphasic morphology with the highest values of HIRI (P<0.02) and IGI (P<0.007). By combining morphologies of glucose and insulin curves or time of the glucose peak, a deeper characterisation of different phenotypes of glucose metabolism emerged.
CONCLUSIONS: Morphologies of the glucose curve seem reflecting different metabolic phenotypes of insulin action and secretion, particularly when combined with morphologies of insulin curve or time of glucose peak. Such findings may deserve validation in cohort study, in which glucose metabolism would be estimated by using gold standard techniques.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009494     DOI: 10.1530/EJE-11-0827

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

1.  The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.

Authors:  Heba M Ismail; Ping Xu; Ingrid M Libman; Dorothy J Becker; Jennifer B Marks; Jay S Skyler; Jerry P Palmer; Jay M Sosenko
Journal:  Diabetologia       Date:  2017-09-27       Impact factor: 10.122

2.  The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study.

Authors:  Heba M Ismail; Mario A Cleves; Ping Xu; Ingrid M Libman; Dorothy J Becker; Jennifer B Marks; Jay S Skyler; Jerry P Palmer; Jay M Sosenko
Journal:  Diabetes Care       Date:  2020-09-08       Impact factor: 19.112

3.  Time to glucose peak during an oral glucose tolerance test identifies prediabetes risk.

Authors:  Stephanie T Chung; Joon Ha; Anthony U Onuzuruike; Kannan Kasturi; Mirella Galvan-De La Cruz; Brianna A Bingham; Rafeal L Baker; Jean N Utumatwishima; Lilian S Mabundo; Madia Ricks; Arthur S Sherman; Anne E Sumner
Journal:  Clin Endocrinol (Oxf)       Date:  2017-08-06       Impact factor: 3.478

4.  Delayed timing of post-challenge peak blood glucose predicts declining beta cell function and worsening glucose tolerance over time: insight from the first year postpartum.

Authors:  Caroline K Kramer; Chang Ye; Anthony J G Hanley; Philip W Connelly; Mathew Sermer; Bernard Zinman; Ravi Retnakaran
Journal:  Diabetologia       Date:  2015-03-12       Impact factor: 10.122

Review 5.  Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT).

Authors:  Melinda E Chen; Rebecca S Aguirre; Tamara S Hannon
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

6.  The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in β-Cell Function in TODAY.

Authors:  Silva Arslanian; Laure El Ghormli; Joon Young Kim; Fida Bacha; Christine Chan; Heba M Ismail; Lorraine E Levitt Katz; Lynne Levitsky; Jeanie B Tryggestad; Neil H White
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

7.  The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.

Authors:  Joon Young Kim; Sara F Michaliszyn; Alexis Nasr; SoJung Lee; Hala Tfayli; Tamara Hannon; Kara S Hughan; Fida Bacha; Silva Arslanian
Journal:  Diabetes Care       Date:  2016-06-12       Impact factor: 19.112

Review 8.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

9.  OGTT Glucose Response Curves, Insulin Sensitivity, and β-Cell Function in RISE: Comparison Between Youth and Adults at Randomization and in Response to Interventions to Preserve β-Cell Function.

Authors:  Silva A Arslanian; Laure El Ghormli; Joon Young Kim; Ashley H Tjaden; Elena Barengolts; Sonia Caprio; Tamara S Hannon; Kieren J Mather; Kristen J Nadeau; Kristina M Utzschneider; Steven E Kahn
Journal:  Diabetes Care       Date:  2021-01-12       Impact factor: 19.112

10.  Time to the Peak, Shape of the Curve and Combination of These Glucose Response Characteristics During Oral Glucose Tolerance Test as Indicators of Early Beta-cell Dysfunction in Obese Adolescents

Authors:  Lavinia La Grasta Sabolić; Marija Požgaj Šepec; Maja Cigrovski Berković; Gordana Stipančić
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.